Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002

Summary

The primary objective of the study was to assess the efficacy of DA-OTC-002 as a topical cosmetic hair treatment. The investigators conducted a prospective, institution-level, interventional, single-blinded, placebo-controlled investigation to assess the efficacy of a combination an alpha-1 agonist and a TAAR receptor agonist (DA-OTC-002) as a topical cosmetic hair treatment.

Timeline

Start

2022-11-18

Primary completion

2023-01-02

Completion

2023-01-02

Drugs

Indications